deaths from glp-1 receptor agonists and risk of suicide or suicide attempts – A nationwide cohort and self-controlled case series study GLP-1 medications found to reduce

Rachel Sorvig, a spokesperson for Zepbound and Mounjaro manufacturer Eli Lilly, said in a statement that users should "talk to their health care provider about dosage and duration needs." Studies have shown that people typically regain a substantial amount of weight within a year of stopping GLP-1 medications, and that many people who quit ultimately go back on the drugs

Understanding this timeline helps you prepare mentally and physically, and knowing what's normal versus concerning can reduce treatment anxiety and improve your chances of sticking with your plan

L-: L- ,

Fats are how you build your hormones and without them, your body will have a difficult time create the hormones you need

Treatment of breast cancer with gonadotropin-releasing hormone analogs